(Q37912042)

25 August 2017

1 reference

title

TG2, a novel extracellular protein with multiple functions (English)

1 reference

25 August 2017

0 references

Zhuo Wang

1

1 reference

PubMed ID

21818567

25 August 2017

Martin Griffin

series ordinal

2

1 reference

25 August 2017

5 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

42

1 reference

25 August 2017

2-3

1 reference

25 August 2017

939-949

1 reference

https://scigraph.springernature.com/pub.10.1007/s00726-011-1008-x

25 August 2017

0 references

cites work

Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

The cellular response to transglutaminase-cross-linked collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminases: nature's biological glues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Synthesis of potent water-soluble tissue transglutaminase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

A novel function of tissue-type transglutaminase: protein disulphide isomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Involvement of tissue transglutaminase in the stabilisation of biomaterial/tissue interfaces important in medical devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase inhibition ameliorates experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase and the progression of human renal scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase (TG2) in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase: from biological glue to cell survival cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase 2 inhibitors and their therapeutic role in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Future therapeutic options for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Redox regulation of transglutaminase 2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Over-expression of integrin beta3 can partially overcome the defect of integrin beta3 signaling in transglutaminase 2 null macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase in normal and abnormal wound healing: review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

Transglutaminase-catalyzed crosslinking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-1008-X

10.1007/S00726-011-1008-X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21818567